您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [美股财报]:LifeStance Health Group Inc. 2025年季度报告 - 发现报告

LifeStance Health Group Inc. 2025年季度报告

2025-05-07 美股财报 梅斌
报告封面

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant toRule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No☒As of April 30, 2025, the registrant had388,875,906shares of common stock, $0.01 par value per share, outstanding. Table of Contents PART I.FINANCIAL INFORMATION Item 1.Financial Statements (Unaudited)1Consolidated Balance Sheets2Consolidated Statements of Operations and Comprehensive Income (Loss)3Consolidated Statements of Changes in Stockholders' Equity4Consolidated Statements of Cash Flows5Notes to Consolidated Financial Statements6Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations15Item 3.Quantitative and Qualitative Disclosures about Market Risk23Item 4.Controls and Procedures23 PART II.OTHER INFORMATIONItem 1.Legal ProceedingsItem 1A.Risk FactorsItem 2.Unregistered Sales of Equity Securities and Use of ProceedsItem 3.Defaults Upon Senior SecuritiesItem 4.Mine Safety DisclosuresItem 5.Other InformationItem 6.ExhibitsSignatures Cautionary Note Regarding Forward-Looking Statements This Quarterly Report on Form 10-Q contains forward-looking statements. Forward-looking statements are neither historicalfacts nor assurances of future performance. Instead, they are based on our current beliefs, expectations and assumptions regardingthe future of our business, future plans and strategies, and other future conditions. Forward-looking statements can be identified bywords such as “anticipate,” “believe,” “envision,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “target,”“potential,” “will,” “would,” “could,” “should,” “continue,” “contemplate” and other similar expressions, although not all forward-looking statements contain these identifying words. For example, all statements we make relating to: our ability to grow our We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and youshould not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans,intentions and expectations disclosed in the forward-looking statements we make. We have based these forward-looking statementslargely on our current expectations and projections about future events and trends that we believe may affect our financialcondition, results of operations, business strategy and financial needs. These forward-looking statements are subject to a number of •if reimbursement rates paid by third-party payors are reduced or if third-party payors otherwise restrain our ability toobtain or deliver care to patients, our business could be materially harmed;•we may not grow at the rates we historically have achieved or at all, even if our key metrics may imply future growth,including if we are unable to successfully execute on our growth initiatives and business strategies;•if we fail to manage our growth effectively, our expenses could increase more than expected, our revenue may notincrease proportionally or at all, and we may be unable to execute on our business strategy;•our ability to recruit new clinicians and retain existing clinicians;•we conduct business in a heavily regulated industry and if we fail to comply with these laws and governmentregulations, we could incur penalties or be required to make significant changes to our operations or experience adversepublicity, which could have a material adverse effect on our business, results of operations and financial condition; PART I—FINANCIAL INFORMATION Item 1. Financial Statements (Unaudited). LIFESTANCE HEALTH GROUP, INC.CONSOLIDATED FINANCIAL STATEMENTSFor the quarterly period ended March 31, 2025 LIFESTANCE HEALTH GROUP, INC.CONSOLIDATEDBALANCE SHEETS(unaudited) LIFESTANCE HEALTH GROUP, INC.CONSOLIDATEDSTATEMENTS OF CASH FLOWS(unaudited) LIFESTANCE HEALTH GROUP, INC.NOTES TO CONSOLIDATED FINANCIAL